Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

NLK

RBC: NLK · Substrate: MBP ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Dasatinib75.10.70
Darovasertib72.60.72
Encorafenib71.30.76
Pemigatinib51.30.72
Bosutinib45.90.55
Ripretinib44.40.67
Dabrafenib33.30.63
Pazopanib32.30.67
Zanubrutinib30.00.79
Tivozanib25.00.67
Ceritinib17.20.62
Ponatinib16.80.53
Gefitinib15.30.65
Lenvatinib10.70.73
Dacomitinib10.60.66

Known variants

No variants catalogued.
Open in new tab